ARS Pharmaceuticals, Inc. (SPRY)
(Real Time Quote from BATS)
$11.28 USD
-0.38 (-3.26%)
Updated Jul 16, 2024 03:45 PM ET
After-Market: $11.31 +0.03 (0.27%) 4:06 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.13 | 0.00% |
Earnings Summary
For their last quarter, ARS Pharmaceuticals, Inc. (SPRY) reported earnings of -$0.11 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for SPRY's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.13 per share, reflecting a year-over-year increase of 27.78%.
Earnings History
Price & Consensus
Zacks News for SPRY
Recent Price Trend in ARS Pharmaceuticals, Inc. (SPRY) is Your Friend, Here's Why
SPRY: What are Zacks experts saying now?
Zacks Private Portfolio Services